Federal award
BIOMERIEUX INC
W81K0021P0092
Contract
Obligated and Ceiling
- Obligated (net)
- $80,511.26
- Ceiling (potential value, not spending)
- $97,937.76
- Current value
- $97,937.76
- Gross positive obligations
- $102,887.35
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BIOMERIEUX INC · HCNVCMEG9NL6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- BIOMERIEUX INC · HCNVCMEG9NL6
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0021P0092
- Award type code
- B
- Actions
- 12 · Jun 2, 2021 to May 14, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History12
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 14, 2026 | FY2026 | P00011 | B | $3,970.40 | — |
| Mar 6, 2026 | FY2026 | P00010 | C | −$22,376.09 | — |
| Dec 16, 2025 | FY2026 | P00009 | C | $19,763.83 | — |
| Apr 21, 2025 | FY2025 | P00008 | G | $0.00 | — |
| Dec 2, 2024 | FY2025 | P00007 | C | $19,763.83 | — |
| Jan 26, 2024 | FY2024 | P00006 | G | $0.00 | — |
| Oct 31, 2023 | FY2024 | P00005 | C | $19,796.43 | — |
| Aug 8, 2023 | FY2023 | P00004 | G | $0.00 | — |
| Oct 12, 2022 | FY2023 | P00003 | C | $19,796.43 | — |
| Aug 10, 2022 | FY2022 | P00002 | G | $0.00 | — |
| Oct 14, 2021 | FY2022 | P00001 | C | $19,796.43 | — |
| Jun 2, 2021 | FY2021 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.